Skip to main content
Premium Trial:

Request an Annual Quote

NCI Sets Aside $10M in RFA to Encourage Proteomic Tech Development

NEW YORK, Dec. 9, (GenomeWeb News) - The National Cancer Institute intends to commit around $10 million in 2006 to fund approximately 10 new grants as part of its Clinical Proteomic Technologies Initiative, the institute said today.


In an RFA posted on its web site, the institute invites grant applications for "highly innovative research in the quantitative analysis of proteins and peptides of interest" in clinical cancer studies.


GenomeWeb News reported in October NCI's notice of intent for RFAs for advanced proteomic platforms, analytical methods, and computational sciences.


Titled "Advanced Proteomic Platforms and Computational Sciences for the NCI Clinical Proteomic Technologies Initiative," the RFA has receipt dates in early spring of 2006.


NCI described the technologies initiative as an "integrated approach to develop and enhance proteomic technology capabilities" on its web site.


More information can be found  here.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.